Search research articles
Contact Us
Filters
Showing results (221-230 of 322) with videos related to
Page
of 33
Sort By:
Cancer
|
January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808
Jonathan E Kolitz, Stephen L George, Don M Benson, et al.
Haematologica
|
January 29, 2026
Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors
Joseph M Cannova, Muriel R Battaglia, Gregory W Roloff, et al.
Blood Advances
|
May 29, 2024
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia
Andrew Palmer, Garth Rauscher, Ivy Abraham, et al.
British Journal of Haematology
|
November 19, 2014
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia
Robert K Stuart, Larry D Cripe, Michael B Maris, et al.
American Journal of Hematology
|
March 15, 2020
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403
Lawrence D Kaplan, Matthew J Maurer, Wendy Stock, et al.
Blood Advances
|
November 15, 2019
Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults
Benjamin A Derman, Keriann Kordas, Jean Ridgeway, et al.
Blood Advances
|
April 12, 2024
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL
Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, et al.
Blood Advances
|
February 20, 2020
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia
Kirk E Cahill, Yasmin H Karimi, Theodore G Karrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, et al.
Page
of 33
Search research articles
Search
Showing results (221-230 of 322) with videos related to
Sort By:
Page
of 33
Cancer
|
January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808
Jonathan E Kolitz, Stephen L George, Don M Benson, et al.
Haematologica
|
January 29, 2026
Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors
Joseph M Cannova, Muriel R Battaglia, Gregory W Roloff, et al.
Blood Advances
|
May 29, 2024
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia
Andrew Palmer, Garth Rauscher, Ivy Abraham, et al.
British Journal of Haematology
|
November 19, 2014
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia
Robert K Stuart, Larry D Cripe, Michael B Maris, et al.
American Journal of Hematology
|
March 15, 2020
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403
Lawrence D Kaplan, Matthew J Maurer, Wendy Stock, et al.
Blood Advances
|
November 15, 2019
Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults
Benjamin A Derman, Keriann Kordas, Jean Ridgeway, et al.
Blood Advances
|
April 12, 2024
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL
Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, et al.
Blood Advances
|
February 20, 2020
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia
Kirk E Cahill, Yasmin H Karimi, Theodore G Karrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity
Guido Marcucci, Wendy Stock, Guowei Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, et al.
Page
of 33